Page last updated: 2024-12-11
sarcodictyin a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
sarcodictyin A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5478977 |
CHEMBL ID | 370543 |
MeSH ID | M0284270 |
Synonyms (4)
Synonym |
---|
sarcodictyin a |
CHEMBL370543 |
methyl (1r,2e,4s,5r,9r,11s,12s)-1-hydroxy-8,12-dimethyl-11-[(e)-3-(1-methylimidazol-4-yl)prop-2-enoyl]oxy-5-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-2,7,13-triene-2-carboxylate |
sarcodictyin-a |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (4)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID254570 | Tubulin polymerization at a concentration of 100 uM incubated for 90 minutes | 2005 | Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18 | Joys of molecules. 2. Endeavors in chemical biology and medicinal chemistry. |
AID255811 | Inhibition concentration against human ovarian 1A9 tumor cells | 2005 | Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18 | Joys of molecules. 2. Endeavors in chemical biology and medicinal chemistry. |
AID355718 | Cytotoxicity against human HeLa cells | 2003 | Journal of natural products, Apr, Volume: 66, Issue:4 | (Z)-sarcodictyin A, a new highly cytotoxic diterpenoid from the soft coral Bellonella albiflora. |
AID255450 | Tubulin polymerization at a concentration of 100 uM incubated for 90 minutes | 2005 | Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18 | Joys of molecules. 2. Endeavors in chemical biology and medicinal chemistry. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.34
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.34) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (14.29%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (85.71%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |